Trevisan G, Germi L, Naldi L. Erythrodermic psoriasis improved by tildrakizumab. Dermatol Reports [Internet]. 2022 Nov. 23 [cited 2024 Dec. 4];14(4). Available from: https://www.pagepress.org/journals/dr/article/view/9448